<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD00080000_1</Organism_ID>
  <Organism>Rat</Organism>
  <Organism_Latin>Rattus norvegicus</Organism_Latin>
  <UniProt_ID>P28564</UniProt_ID>
  <Seq_Length>386</Seq_Length>
  <Molecule_Weight>43163</Molecule_Weight>
  <KEGG_ID>rno:25075</KEGG_ID>
  <Orthology_ID>K04153</Orthology_ID>
  <Function_Summary>This is one of the several different receptors for 5-hydroxytryptamine (serotonin), a biogenic hormone that functions as a neurotransmitter, a hormone, and a mitogen. The activity of this receptor is mediated by G proteins that inhibit adenylate cyclase activity.</Function_Summary>
  <Pfam_ID>PF00001:7tm_1</Pfam_ID>
  <Allosteric_Activator_Count>0</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>1</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>5-HT-1B</Alias>
      <Alias>Serotonin receptor 1B</Alias>
      <Alias>5-HT1B</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Combining with an extracellular or intracellular messenger to initiate a change in cell activity.</Detail>
      <Keyword>Receptor activity</Keyword>
      <Ontology_ID>GO:0004872</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with a drug, any naturally occurring or synthetic substance, other than a nutrient, that, when administered or applied to an organism, affects the structure or functioning of the organism; in particular, any such substance used in the diagnosis, prevention, or treatment of disease.</Detail>
      <Keyword>Drug binding</Keyword>
      <Ontology_ID>GO:0008144</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Combining with the biogenic amine serotonin, a neurotransmitter and hormone found in vertebrates, invertebrates and plants, to initiate a change in cell activity.</Detail>
      <Keyword>Serotonin receptor activity</Keyword>
      <Ontology_ID>GO:0004993</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with serotonin (5-hydroxytryptamine), a monoamine neurotransmitter occurring in the peripheral and central nervous systems, also having hormonal properties.</Detail>
      <Keyword>Serotonin binding</Keyword>
      <Ontology_ID>GO:0051378</Ontology_ID>
    </Funtion>
  </Function_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>The specific actions or reactions of an organism relating to the intake of liquids, especially water.</Detail>
      <Keyword>Drinking behavior</Keyword>
      <Ontology_ID>GO:0042756</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cocaine stimulus. Cocaine is a crystalline alkaloid obtained from the leaves of the coca plant.</Detail>
      <Keyword>Response to cocaine</Keyword>
      <Ontology_ID>GO:0042220</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the frequency, rate or extent of the regulated release of dopamine.</Detail>
      <Keyword>Regulation of dopamine secretion</Keyword>
      <Ontology_ID>GO:0014059</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process of communication from a neuron to a target (neuron, muscle, or secretory cell) across a synapse.</Detail>
      <Keyword>Synaptic transmission</Keyword>
      <Ontology_ID>GO:0007268</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mineralocorticoid stimulus. Mineralocorticoids are hormonal C21 corticosteroids synthesized from cholesterol and characterized by their similarity to aldosterone. Mineralocorticoids act primarily on water and electrolyte balance.</Detail>
      <Keyword>Response to mineralocorticoid stimulus</Keyword>
      <Ontology_ID>GO:0051385</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ethanol stimulus.</Detail>
      <Keyword>Response to ethanol</Keyword>
      <Ontology_ID>GO:0045471</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The series of molecular signals generated as a consequence of a G-protein coupled receptor binding to its physiological ligand.</Detail>
      <Keyword>G-protein coupled receptor protein signaling pathway</Keyword>
      <Ontology_ID>GO:0007186</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate or extent of GABAergic synaptic transmission, the process of communication from a neuron to another neuron across a synapse using the neurotransmitter gamma-aminobutyric acid (GABA).</Detail>
      <Keyword>Negative regulation of synaptic transmission, GABAergic</Keyword>
      <Ontology_ID>GO:0032229</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal, e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light, and ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell, and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.</Detail>
      <Keyword>Signal transduction</Keyword>
      <Ontology_ID>GO:0007165</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate or extent of glutamatergic synaptic transmission, the process of communication from a neuron to another neuron across a synapse using the neurotransmitter glutamate.</Detail>
      <Keyword>Negative regulation of synaptic transmission, glutamatergic</Keyword>
      <Ontology_ID>GO:0051967</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <Molecule_Seq>
    <Protein_Seq>MEEQGIQCAPPPPATSQTGVPLANLSHNCSADDYIYQDSIALPWKVLLVALLALITLATTLSNAFVIATVYRTRKLHTPANYLIASLAVTDLLVSILVMPISTMYTVTGRWTLGQVVCDFWLSSDITCCTASIMHLCVIALDRYWAITDAVDYSAKRTPKRAAIMIVLVWVFSISISLPPFFWRQAKAEEEVLDCFVNTDHVLYTVYSTVGAFYLPTLLLIALYGRIYVEARSRILKQTPNKTGKRLTRAQLITDSPGSTSSVTSINSRVPEVPSESGSPVYVNQVKVRVSDALLEKKKLMAARERKATKTLGIILGAFIVCWLPFFIISLVMPICKDACWFHMAIFDFFNWLGYLNSLINPIIYTMSNEDFKQAFHKLIRFKCTG</Protein_Seq>
    <DNA_Seq>CAAGAGCTGCGCTCCGCAGCCAGGACGAGGAGAGCTATGGAGGAGCAGGGTATTCAGTGCGCTCCGCCGCCTCCCGCCACCTCCCAGACAGGGGTACCTCTCGCCAACCTCTCCCACAACTGCAGCGCCGACGACTACATTTACCAGGACTCCATCGCCCTGCCCTGGAAAGTCCTGCTGGTTGCTTTGTTAGCGCTCATCACCTTGGCCACCACGCTCTCCAACGCCTTTGTAATCGCTACGGTGTATCGGACCCGGAAGCTGCACACCCCGGCTAACTACCTGATCGCCTCGCTGGCAGTCACTGACCTGCTCGTGTCCATCCTGGTGATGCCCATCAGCACCATGTACACGGTCACTGGACGCTGGACACTAGGCCAGGTGGTCTGCGACTTCTGGCTGTCGTCGGATATCACCTGTTGCACTGCTTCCATCATGCATCTCTGTGTCATCGCCCTGGACCGCTACTGGGCCATCACTGATGCGGTGGACTATTCTGCTAAAAGAACTCCCAAAAGGGCGGCCATCATGATCGTGCTGGTGTGGGTCTTCTCCATCTCGATTTCGCTGCCACCCTTCTTCTGGCGTCAAGCCAAAGCGGAGGAGGAGGTGCTGGACTGCTTTGTGAACACCGACCACGTCCTCTACACGGTCTACTCCACGGTGGGGGCTTTCTATTTACCCACCCTGCTCCTCATCGCCCTCTATGGCCGTATCTATGTGGAAGCCCGCTCTCGGATTTTGAAACAGACACCCAACAAGACCGGCAAGCGCTTGACCCGAGCCCAGTTGATAACAGACTCTCCAGGATCCACGTCCTCGGTCACCTCCATTAACTCCCGGGTTCCGGAGGTGCCCAGTGAGTCCGGGTCTCCTGTGTACGTGAACCAAGTCAAAGTGCGAGTCTCAGACGCCCTGCTGGAAAAGAAGAAACTCATGGCCGCTAGGGAGCGCAAAGCCACCAAGACCCTAGGGATCATTTTAGGAGCATTTATTGTGTGCTGGCTCCCCTTCTTCATCATCTCCCTGGTGATGCCTATCTGCAAGGATGCCTGCTGGTTTCACATGGCCATTTTTGACTTTTTCAATTGGCTAGGCTATCTTAACTCTCTCATCAACCCCATCATCTACACCATGTCCAATGAGGACTTCAAACAAGCATTCCATAAACTGATACGCTTTAAGTGCACAGGTTGACTTGTCAATGGCATTGGGGTCGCCTAAGGCCATTTGGGGACCAAGTTGGGTCTT</DNA_Seq>
  </Molecule_Seq>
  <Tissuelocal_List>
    <TissueLocal>
      <TissueLocal>Blood vessels</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Central nervous system</TissueLocal>
    </TissueLocal>
  </Tissuelocal_List>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cell membrane</CellLocal>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Membrane Associated</CellLocal>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>Htr1b</Gene_Name>
    <Gene_Alias>5ht1b</Gene_Alias>
    <Gene_ID>25075</Gene_ID>
    <Genbank_ACCN>NM_022225</Genbank_ACCN>
    <Protein_ACCN>NP_071561</Protein_ACCN>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/25075</Gene_URL>
    <EMBL_ID>ENSRNOG00000013042</EMBL_ID>
  </Gene>
  <PDB_List>
    <PDB>
      <PDB_Title>Model of 5-hydroxytryptamine receptor 1B</PDB_Title>
      <PDB_ID>ASD00080000_1</PDB_ID>
      <Resolution>-1.0</Resolution>
      <Has_Ligand>No</Has_Ligand>
    </PDB>
  </PDB_List>
  <Modulator_List>
    <Modulator>
      <ASD_ID>ASD00080001</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
  </Modulator_List>
  <Create_Date>2012-05-31</Create_Date>
</Organism_Record>